Graz diabetes registry for studying blood biomarkers
Part of Hormones & metabolism clinical trials.
This study is a diabetes registry that collects health and blood information to learn what “biomarkers” (measurable signs in the body) can tell us about diabetes and related conditions. It may help researchers better understand diabetes and possibly improve future testing or care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 99 years old
- You must give written informed consent to join
- You must have at least one of these: type 1, type 2, type 3 diabetes, MODY, LADA, obesity (BMI over 30), or a lipid (fat) metabolism disorder
- You must be willing to participate in the registry
- If you do not provide written consent, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a research registry that collects information from people who have diabetes (high blood sugar on tests or based on diabetes treatment). It may help researchers understand diabetes patterns in a real-world healthcare system.
This trial looks at fat stored around the heart in people with type 2 diabetes, using samples already collected from a larger study. Researchers want to understand how this fat relates to diabetes, but it does not test any new drug or treatment.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This study creates a diabetes “registry,” which is a large record of people with diabetes. It helps researchers understand diabetes patterns and how metabolic health changes over time, which may improve future care.
This study is a registry that collects information from people with diabetes, prediabetes, or normal blood sugar to better understand these conditions over time. It may help researchers learn which factors are linked to health changes, including future diabetes risk.
This study collects information about people with diabetes to better understand the condition in everyday life. It may help improve future diabetes care by building a real-world diabetes database.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.